Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03694522
Brief Title: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (FIGHT) (FIGHT)

First Submitted : September 14, 2018
First Submitted that Met QC Criteria : October 1, 2018
First Posted : October 3, 2018

Last Update Submitted that Met QC Criteria : April 30, 2021
Last Update Posted : May 3, 2021